Turnstone Biologics rides biotech's IPO train in Friday debut
Turnstone Biologics raised $80 million in a Friday morning IPO under the ticker $TSBX, bookending a rare two-week stretch for biotech listings.
The startup follows …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.